For instance, in NSCLC, PCAT6 interacts with EZH2 epigenetically, suppressing LATS2,48 while in colon cancer, the association of PCAT6 with EZH2 modulates ARC expression.49 Here, EZH2 is linked to malignant colon neoplasm.